Skip to main content
    K

    Kodiak Sciences Inc (KOD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $88.12
    +7.03 (+8.67%)

    Market Cap: $5.76B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(14/32)
    Avg Surprise
    -4.93%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.01
    Range$-1.10 - $-0.89
    5 analysts
    EPS RevisionsNo revisions (7d)
    0
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.93-8.5%
    60d ago$-0.92-9.7%
    30d ago$-1.01+0.2%
    7d ago$-1.01+0.2%
    Current$-1.01
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.00
    Range$-1.23 - $-0.77
    5 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.00---
    Sep 26EST
    		-$-1.01---
    Jun 26
    Reported Aug 12
    		$-1.05$-0.97-8.25%Miss-1.9%
    Mar 26
    Reported May 7
    		$-0.94$-1.01+6.93%Beat+13.8%
    Dec 25
    Reported Mar 31
    		$-1.04$-1.01-2.97%Miss-23.8%
    Sep 25
    Reported Nov 13
    		$-1.16$-1.04-11.54%Miss-38.1%
    Jun 25
    Reported Aug 13
    		$-1.03$-1.05+1.90%Beat-19.8%
    Mar 25
    Reported May 14
    		$-1.09$-0.87-25.29%Miss-32.9%
    Dec 24
    Reported Mar 27
    		$-0.84$-0.86+2.78%Beat+25.7%
    Sep 24
    Reported Nov 14
    		$-0.84$-0.90+6.67%Beat+11.6%
    Jun 24
    Reported Aug 14
    		$-0.86$-0.85-1.18%Miss+43.8%
    Mar 24
    Reported May 15
    		$-0.82$-1.06+22.64%Beat+39.3%
    Dec 23
    Reported Mar 28
    		$-1.13$-0.77-46.75%Miss+16.3%
    Sep 23
    Reported Nov 14
    		$-0.95$-1.35+29.63%Beat+35.4%
    Jun 23
    Reported Aug 14
    		$-1.53$-1.15-33.04%Miss+12.1%
    Mar 23
    Reported May 15
    		$-1.35$-1.37+1.46%Beat+26.2%
    Dec 22
    Reported Mar 28
    		$-1.35$-1.52+11.18%Beat+24.6%
    Sep 22
    Reported Nov 9
    		$-1.47$-1.71+14.04%Beat-13.1%
    Jun 22
    Reported Aug 9
    		$-1.74$-1.74+0.00%Beat-61.1%
    Mar 22
    Reported May 10
    		$-1.83$-1.56-17.31%Miss-86.7%
    Dec 21
    Reported Mar 1
    		$-1.79$-1.36-31.62%Miss-84.5%
    Sep 21
    Reported Nov 9
    		$-1.30$-1.18-10.17%Miss-62.5%
    Jun 21
    Reported Aug 9
    		$-1.08$-1.03-4.85%Miss-86.2%
    Mar 21
    Reported May 10
    		$-0.98$-0.98+0.00%Beat-81.5%
    Dec 20
    Reported Mar 1
    		$-0.97$-0.80-21.25%Miss-142.5%
    Sep 20
    Reported Nov 9
    		$-0.80$-0.70-14.29%Miss-142.4%
    Jun 20
    Reported Aug 10
    		$-0.58$-0.57-1.75%Miss-87.1%
    Mar 20
    Reported May 11
    		$-0.54$-0.46-17.39%Miss-157.1%
    Dec 19
    Reported Mar 16
    		$-0.40$-0.35-14.29%Miss-60.0%
    Sep 19
    Reported Nov 12
    		$-0.33$-0.33+0.00%Beat+13.2%
    Jun 19
    Reported Aug 14
    		$-0.31$-0.29-6.90%Miss+69.3%
    Mar 19
    Reported May 15
    		$-0.21$-0.37+43.24%Beat-
    Dec 18
    Reported Mar 28
    		$-0.25$-0.30+16.67%Beat-
    Sep 18
    Reported Oct 5
    		$-0.38$-0.26-46.15%Miss-
    Jun 18
    Reported Aug 29
    		$-1.01$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-21.03EV/EBITDAN/A
    Price/FCF-34.51xFCF Yield-2.90%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-368.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.49xQuick Ratio2.49x
    Trading Statistics
    Beta2.04Avg Volume3.69M
    52-Week High$104.0052-Week Low$13.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$92.59
    SMA 20$74.81
    SMA 50$52.80
    SMA 200$38.54
    EMA 10$87.87
    EMA 20$77.97
    EMA 50$60.62
    EMA 200$40.49

    MACD

    Line: 13.18Signal: 13.75Hist: -0.57

    ADX

    ADX: 49.3+DI: 34.8-DI: 21.4

    Aroon & PSAR

    Aroon Up60.0
    Aroon Down40.0
    PSAR$66.88

    Bollinger Bands

    Upper Band$132.00
    Lower Band$17.63
    %B Position15288%(Upper)
    Band Width0.62

    RSI (14-Day)

    Neutral
    63.4

    Momentum Oscillators

    Stoch %K71.8
    Stoch %D81.4
    Williams %R-36.5
    ROC (10d)-10.5%
    Momentum-10.34
    CCI (20d)29.3
    MFI (14d)81.5

    Volatility Measures

    ATR (14d)$7.55(8.6%)
    StdDev (20d)28.59
    Hist Vol636.8%(High)

    Volume Flow

    VWAP$85.23
    OBV79.5M
    AD Line43.6M
    CMF (20d)0.408

    Volume Metrics

    Avg Vol (20d)4.0M
    Vol Ratio0.4x(Low)
    VWMA (20d)$85.58

    Pivot Points

    R3$98.24
    R2$94.43
    R1$87.76
    Pivot Point$83.95
    S1$77.28
    S2$73.47
    S3$66.80

    Advanced Oscillators

    TSI48.67
    Ultimate Osc55.8
    KST1509.67

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$26.65M$0$0$0$0$0
    Cost of Revenue$0$0$-19,805,000$0$0$0$6.68M$0$0$0$6.66M$0
    Gross Profit$0$0$19.80M$0$0$0$-6,682,000$0$0$0$-6,664,000$0
    Operating Expenses$66.84M$59.78M$57.45M$62.35M$55.51M$59.07M$46.18M$46.63M$47.98M$46.05M$63.37M$54.50M
    R&D$56.08M$48.55M$45.49M$50.48M$42.76M$43.64M$31.77M$31.88M$32.51M$29.93M$46.63M$36.19M
    SG&A$10.76M$11.23M$11.96M$11.88M$12.75M$15.43M$14.41M$14.75M$15.47M$16.12M$16.75M$18.31M
    Operating Income$-66,838,000$-59,777,000$-57,453,000$-62,352,000$-55,510,000$-59,073,000$-46,179,000$-46,632,000$-47,983,000$-46,055,000$-63,374,000$-54,500,000
    Interest Income$1.25M$1.64M$757,000$917,000$1.24M$1.60M$2.13M$2.71M$2.95M$3.35M$3.90M$4.54M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$5,000
    Income Before Tax$-65,643,000$-58,158,000$-56,736,000$-61,457,000$-54,313,000$-57,461,000$-44,105,000$-43,946,000$-45,117,000$-43,039,000$-59,516,000$-50,007,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-65,643,000$-58,158,000$-56,736,000$-61,457,000$-54,313,000$-57,461,000$-44,105,000$-43,946,000$-45,117,000$-43,039,000$-59,516,000$-50,007,000
    EBITDA$-60,710,000$-53,459,000$-50,978,000$-55,835,000$-49,016,000$-52,335,000$-39,553,000$-39,960,000$-41,390,000$-39,746,000$-56,753,000$-47,568,000
    EBIT$-66,898,000$-59,799,000$-57,493,000$-62,374,000$-55,554,000$-59,063,000$-46,235,000$-46,657,000$-48,071,000$-46,392,000$-63,413,000$-54,538,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about KOD

    News

    HC Wainwright raises target for Kodiak Sciences stock to USD 126.00

    HC Wainwright has increased its price target for Kodiak Sciences (KOD) stock from $96.00 to $126.00, maintaining a "Buy" rating. This adjustment comes despite Kodiak reporting a Q2 2026 loss of $1.05 per share...

    ad-hoc-news.de•10/15/26•Bullish

    KOD Stock Rockets As DAYBREAK Trial Rewrites Biotech Expectations

    Kodiak Sciences Inc (KOD) shares surged after its Zenkuda and tabirafusp-ted drugs met Phase 3 endpoints in the DAYBREAK trial for wet age-related macular degeneration (wet AMD)...

    Timothy Sykes•10/15/26•Bullish

    KOD Stock Soars As Zenkuda Trial Fuel Sparks Massive Re‑Rating

    Kodiak Sciences Inc (KOD) shares surged after its Phase 3 DAYBREAK trial for Zenkuda and tabirafusp-ted in wet age-related macular degeneration met primary endpoints, showing non-inferior vision gains, strong durability...

    StocksToTrade•10/15/26•Bullish

    KOD Stock Rockets As DAYBREAK Trial Rewrites Biotech Expectations

    Kodiak Sciences Inc (KOD) shares surged after its Zenkuda and tabirafusp-ted drugs met Phase 3 endpoints in the DAYBREAK trial for wet age-related macular degeneration (wet AMD)...

    Timothy Sykes•10/15/26•Bullish

    HC Wainwright & Co. maintains Buy rating on Kodiak Sciences, $126 price target

    HC Wainwright & Co. has reiterated its Buy rating on Kodiak Sciences (KOD) and set a price target of $126.00, suggesting a 26.2% upside from the recent closing price. This positive outlook is driven by successful Phase 3...

    TradingView•10/12/26•Bullish

    KOD Valuation and Fair Value

    P/E
    -21.0x
    P/FCF
    -34.5x
    P/B
    90.3x
    See GNG's fair value

    KOD Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -368.4%
    FCF yield
    -2.9%

    KOD Competitors

    CompanyTicker
    Immunovant IncIMVT
    Haemonetics CorporationHAE
    Ligand Pharmaceuticals IncorporatedLGND
    CG Oncology, Inc. Common stockCGON
    Rhythm Pharmaceuticals IncRYTM
    Doximity IncDOCS
    Kiniksa Pharmaceuticals LtdKNSA
    RadNet IncRDNT

    Sector: Healthcare

    KOD Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    5
    Hold
    1
    Sell
    0
    Strong Sell
    0

    KOD Bull Case vs Bear Case

    Bull case

    • 85.7% of KOD's analyst ratings are Buy or Strong Buy.

    KOD Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -3.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 5 down

    Frequently Asked Questions About KOD

    Does KOD pay dividends?

    Kodiak Sciences Inc (KOD) does not currently pay a regular dividend.

    What is KOD's market cap?

    Kodiak Sciences Inc (KOD) has a market capitalization of $5.76B with a current stock price of $88.12.

    Related stocks

    Sector: Healthcare

    All stocks starting with K

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In